1h Free Analyst Time
The botanical and plant-derived drugs market is forecasted to grow by USD 20.93 bn during 2023-2028, accelerating at a CAGR of 8.18% during the forecast period. The report on the botanical and plant-derived drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising government initiatives to promote the use of plant-derived drugs, limitations associated with conventional drugs, and growing demand for effective treatment of chronic disorders.
The botanical and plant-derived drugs market is segmented as below:
By Type
- Oral
- Injectables
- Topicals
By Application
- Infectious diseases
- Central nervous system
- Cardiovascular diseases
- Respiratory diseases
- Digestive diseases and others
By Geographical Landscape
- Asia
- Europe
- North America
- Rest of World (ROW)
The report on the botanical and plant-derived drugs market covers the following areas:
- Botanical and plant-derived drugs market sizing
- Botanical and plant-derived drugs market forecast
- Botanical and plant-derived drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global botanical and plant-derived drugs market: Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, Devonian Health Group Inc., Dr. Willmar Schwabe GmbH and Co. KG, F. Hoffmann La Roche Ltd., Hetero Labs Ltd., Jaguar Health Inc., Jazz Pharmaceuticals Plc, Medigene AG, Merck KGaA, Novartis AG, Pfizer Inc., Pierre Fabre SA, Protalix Biotherapeutics Inc., Riaan Wellness Pvt. Ltd., Wilson Drugs and Pharmaceuticals Pvt. Ltd., Zea Biosciences Corp, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Vertex Pharmaceuticals Inc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the transformation of the regulatory landscape in US."
According to the report, one of the major drivers for this market is the rising government initiatives to promote the use of plant-derived drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bausch Health Companies Inc.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Devonian Health Group Inc.
- Dr. Willmar Schwabe GmbH and Co. KG
- F. Hoffmann La Roche Ltd.
- Hetero Labs Ltd.
- Jaguar Health Inc.
- Jazz Pharmaceuticals Plc
- Medigene AG
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Pierre Fabre SA
- Protalix Biotherapeutics Inc.
- Riaan Wellness Pvt. Ltd.
- Wilson Drugs and Pharmaceuticals Pvt. Ltd.
- Zea Biosciences Corp
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Vertex Pharmaceuticals Inc.
